Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
| Metric | ABBV | EW |
|---|
| Close | 294.89 | 92.01 |
| Market Cap | $522B | $53.6B |
| 1M | +12.73% | +6.59% |
| P/E (TTM) | 81.4 | 53.7 |
| Forward P/E | 16.9 | 31.0 |
| P/E 5-Yr Percentile | 62 | 100 |
| P/S | 8.0 | 8.3 |
| P/B | — | 5.1 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $1.7B |
| Revenue YoY | +10.2% | +13.6% |
| Gross Margin | 74.7% | 77.5% |
| Latest Quarter EPS | 2.03 | 0.42 |
| Avg Post-Earnings Move | ±1.7% | ±3.9% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 2 / 2 |
| Shareholder Yield | 2.58% | 2.25% |
| 90-Day Net Insider Buying | −$8.2M | −$3.5M |
ABBV · Revenue, Last 8 Quarters ($B)
EW · Revenue, Last 8 Quarters ($B)
